McNeil Recalls Imodium Multi-Symptom Relief
The company recalled Imodium Multi-Symptom Relief due to a packaging issue.
McNeil Consumer Healthcare, a Fort Washington-based subsidiary of Johnson & Johnson announced on May 17 that it has recalled Imodium Multi-Symptom Relief, 18 Caplets.
According to the company’s website, the recall is due to a packaging issue that make have affected the blister units in the one lot recall.
The product is package on blister cards with six caplets in blister units. The company’s internal quality control discovered the potential for a number of the blister units to have dents with a small pinhole or tear.
McNeil, on their website, said improvements have been made to the packaging line to help prevent the issue from arising in the future.
The product is being recalled at the wholesale level and there does not seem to be any “safety concerns or adverse events related to the reason for the recall.”
However, the recall stated, “You may continue to use the product if there is no hole or tear in the blister unit. If you take a caplet packaged in a damaged blister unit you may not experience the full benefit of the product as intended.”
Consumers with questions can call the Consumer Care Center at 1-888-222-6036.
The Ambler Gazette reported that McNeil has recalled more than 20 products since late 2009 and in April of 2010 recalled more than 136 million children and infant products.